ACADIA Pharmaceuticals Inc (NASDAQ:ACAD): In Tuesday's trading session, ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) shares declined by 2.54%.

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced the completion of an underwritten public offering of 9,200,000 shares of its common stock, including 1,200,000 shares sold pursuant to the full exercise of an option to purchase additional ...

New York, NY -- (SBWIRE) -- 05/20/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Warner Chilcott plc (NASDAQ:WCRX), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), and Peregrine Pharmaceuticals, Inc.

SAN DIEGO, May 20, 2013 (BUSINESS WIRE) -- ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) , a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system ...

Bridgewater, MA -- (SBWIRE) -- 05/20/2013 -- The online StockConsultant latest screen has found a biotech company that produces drugs for central nervous system disorders ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stock with a confirmed breakout ...

ACADIA Pharmaceuticals ACADIA Pharmaceuticals Inc. (ACAD) is expected to book a narrower loss than a year ago when it reports first quarter earnings on Tuesday, May 7, 2013 with analysts expecting a loss of 8 cents per share, up from a loss of 12 cents ...

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on treatments that address unmet medical needs in neurological and related central nervous system disorders, has been selected for addition to the Nasdaq Biotechnology ...

ACADIA Pharmaceuticals Inc. (ACAD: Quote) announced after the bell Tuesday that it intends to offer and sell shares of its common stock in an underwritten public offering.

Acadia Pharmaceuticals Expects $100M in Public Offering. Thursday, May 16, 2013. San Diego-based drugmaker Acadia Pharmaceuticals Inc. has announced a public offering of its common stock, and said it expects gross proceeds to be $100 million.

Repost This. Wilmington, DE -- (SBWIRE) -- 05/15/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Affymax, Inc. (NASDAQ:AFFY) and ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Affymax, Inc. (NASDAQ:AFFY) a ...